Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 6-K

TFA Therapeutics, Inc.

SEC Filing

Filed Jun 25, 2026Accepted Jun 25, 2026, 6:08 AM EDTCIK 1885680Accession 0001213900-26-071711
Share

Company context

Current securities

Recent company filings

  1. 6-K filingSep 2, 2026
  2. 6-K filingJul 27, 2026
  3. 20-F filingMay 15, 2026
  4. NT 20-F filingApr 30, 2026
  5. 6-K filingNov 26, 2025

As-filed source

Primary evidence